| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |